Brain tumor IDH, 1p/19q, and MGMT molecular classification using MRI-based deep learning: an initial study on the effect of motion and motion correction.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: MRI-based deep learning predicts glioma IDH, 1p/19q, and MGMT molecular status and measures the effect of motion and motion correction on those predictions.
Technology: The source compares molecular-classification performance across motion conditions in a brain-tumor imaging cohort.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The source compares molecular-classification performance across motion conditions in a brain-tumor imaging cohort.
- Limitation / still unknown
- The MRI molecular-status result is limited to the reported cohort and acquisition conditions; no external clinical validation is stated.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://europepmc.org/article/MED/35118164 · https://pmc.ncbi.nlm.nih.gov/articles/PMC8794036/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.